Replies to post #394820 on Zeev's Turnips Patch-No Politics (ZEEV)

[was hotlinktuna]

Took .12 loss on EYET at 13.51 after it traded in the 13.70's but couldn't hit my sell spot in the 13.80's.

[marginnayan]

EYET - From Yahoo thread


eyet - presentation - A lot of comments on Lucentis. I thought this was a very good presentation. I think the hit on eyet may be over done in the near term.

27% increase in vision in Macugen in early disease was close to Lucentis.

Need for head to head trials and 2 years of Lucentis data.

50% more injections with Lucentis over 2 years.

Data at ARVO presentation shows the vegf is needed for Nuron survival. Lucentis may hurt that process by blocking all vegf.

Macugen only drug started on Diabetic Rhet. phase 3 and retinal vein inclusion.

Macugen with PDT - phase 3 started. early small study phase 1 60% 3 line gain

Macugen with microspheres - Less dosing

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1607685533&tid=eyet&sid=...